Pharmaceutical Products – Open House Biologics Discount Agreements 2026-02 - Interferon Beta 1A (Finished Medicinal Product: Rebif (R)). The Aim Is To Conclude Drug Discount Contracts In Accordance With Section 130C Paragraph 1 Sgb V For The Active Ingredient Interferon Beta 1A (Finished Medicinal Product: Rebif (R)) As Part Of An Open House Procedure.
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
